About This Article
A recently published article in the Journal of Hepatology, authored by members of Metabolic Continuum Roundtable, discusses the integration of digital pathology (DP) workflows with artificial intelligence (AI) to improve histological analysis for (nonalcoholic) metabolic dysfunction-associated steatohepatitis (NASH/MASH). The article provides an overview of DP/AI tools in development for NASH/MASH, highlighting key regulatory considerations and how these advanced methods have the potential to improve treatment precision, efficacy assessment, and the development of safe and effective therapeutics in the field.
Recommended Materials
Posters
Participant Feasibility: Direct Engagement With Patients to Impact MASH Trial Design and Site Selection
Articles
Adipose tissue measurement in clinical research for obesity, type 2 diabetes and NAFLD/NASH
Posters
NASH PASS®: A Registry To Inform Study Design And Accelerate Patient Enrollment
Related Solutions
NASH (Nonalcoholic Steatohepatitis)
